on 4 Dec 2024
Last Applicant/ Owned by
Takeda Pharmaceuticals International AG
Thurgauerstrasse 130CH-8152 Glattpark-Opfikon
CH
Serial Number
2219812 filed on 8th Sept 2022
Correspondent Address
GOWLING WLG (CANADA) LLP
SUITE 2600, 160 ELGIN STREETOTTAWA
ONTARIO
CA
K1P1C3
Trademark usage description
préparations pharmaceutiques, à savoir thérapie enzymatique substitutive pour le traitement des troubles sanguins thrombotiques.11
2219812
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 42 on 4th Dec 2024 | Advertised |
Submitted for opposition 27 on 8th Nov 2024 | Approval Notice Sent |
Submitted for opposition 26 on 8th Nov 2024 | Approved |
Submitted for opposition 22 on 21st Feb 2024 | Search Recorded |
Submitted for opposition 20 on 21st Feb 2024 | Examiner's First Report |
Submitted for opposition 223 on 21st Feb 2024 | Total Provisional Refusal |
Submitted for opposition 48 on 15th Jan 2024 | Agent Changed |
Submitted for opposition 256 on 5th Sept 2023 | Notification of Possible Opposition Sent |
Submitted for opposition 30 on 8th Sept 2022 | Filed |
Submitted for opposition 228 on 8th Sept 2022 | International Registration |